Project Type(s):
Clinical Research
Principal Investigator(s):
Co-Investigator(s):
- Mary Larimer, PhD
- Susan Collins
- Bonnie Duran
People experiencing chronic homelessness comprise a small yet high-morbidity, high-cost subset of the larger homeless population and are disproportionately impacted by alcohol-related harm. This study proposes a cluster randomized controlled trial of an innovative, community-based, and client-driven program known as the LEAP to explore its impact on substance use and quality of life outcomes among individuals with lived experience of homelessness and alcohol use problems living in Housing First settings. Analyses will test LEAP effectiveness in increasing engagement in meaningful activities, decreasing alcohol use, ameliorating both first- and secondhand alcohol-related harm, and improving quality of life for this population. |
Project Period:
March 1, 2019 — February 28, 2024
Funding Type(s):
Federal
Funder(s):
NIH/NIAAA
NIH/NIAAA
Geographic Area(s):
King County, Seattle/Puget Sound, University of Washington
Practice Type(s):
Community-Based Organizations
Patient Population(s):
Adults
Targeted Condition(s):
Alcohol use disorders/misuse, Homelessness